SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-036548
Filing Date
2024-03-26
Accepted
2024-03-26 17:05:34
Documents
74
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K bcab-20231231.htm   iXBRL 10-K 2288225
2 EX-4.3 bcab-ex4_3.htm EX-4.3 49841
3 EX-10.17 bcab-ex10_17.htm EX-10.17 181123
4 EX-10.24 bcab-ex10_24.htm EX-10.24 70334
5 EX-10.25 bcab-ex10_25.htm EX-10.25 70324
6 EX-23.1 bcab-ex23_1.htm EX-23.1 5750
7 EX-31.1 bcab-ex31_1.htm EX-31.1 13280
8 EX-31.2 bcab-ex31_2.htm EX-31.2 13283
9 EX-32.1 bcab-ex32_1.htm EX-32.1 9351
10 EX-97.1 bcab-ex97_1.htm EX-97.1 67240
11 GRAPHIC img67494665_0.jpg GRAPHIC 106291
12 GRAPHIC img67494665_1.jpg GRAPHIC 37875
13 GRAPHIC img188821179_0.jpg GRAPHIC 29965
  Complete submission text file 0000950170-24-036548.txt   9197336

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bcab-20231231.xsd EX-101.SCH 1363715
78 EXTRACTED XBRL INSTANCE DOCUMENT bcab-20231231_htm.xml XML 1126708
Mailing Address 11085 TORREYANA ROAD SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SAN DIEGO CA 92121 858-558-0708
BioAtla, Inc. (Filer) CIK: 0001826892 (see all company filings)

IRS No.: 851922320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39787 | Film No.: 24784543
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)